Innovate UK
Deputy Director - Healthy Ageing Challenge
Cynthia Bullock leads the innovation activities across the UK Government’s £98 million Healthy Ageing Challenge supporting the development and delivery of products and services that will allow people to remain active, productive, independent and socially connected across generations for as long as possible.
Cynthia has a background in health research, innovation and commercialisation having trained initially as a Biochemist and Molecular Biologist. Most recently, she led the delivery of Health and Life science programmes at Innovate UK, the UK’s innovation agency representing over £400 million of investment across therapeutics, MedTech, diagnostics and digital health technologies. Cynthia has an executive MBA.
ABHI
Executive Director, Diagnostics
Nishan is responsible for leading ABHI’s strategy to make high quality diagnostic technologies accessible to all who need them. ABHI’s focus on earlier detection and treatment of disease aligns with priorities of the NHS Long Term Plan and the potential for the enhanced use of HealthTech to deliver this is significant. He is an Executive Director of the ABHI Board.
In his time at ABHI Nishan has held a variety of roles including as Chief Operating Officer and has worked on commercial and market access policy issues relevant to the HealthTech industry. His regular, personal interaction with government Ministers, officials and NHS leaders has been key to increasing the Association’s impact. He has extensive knowledge of the HealthTech industry and health/government policy.
Nishan has worked in the health technology industry for 15+ years, and has held senior leadership roles in the industry across finance, marketing and commercial functions.
Boston Scientific
Head Of Public Affairs
Currently on a mission re Environmental Sustainability. Net zero a must.
20 plus years in Medical devices: sales, management, marketing, Market Development & Market Access.
PG Diploma in Health Economics York University gave me a platform to move into Health Economics, Policy and Reimbursement. My work in Public Affairs is now linked to my focus on Environmental Sustainability.
I chair the ABHI Sustainability group, Vice-chair the Commercial policy group, and sit on the Board of HealthTech Ireland.
Passed course from University of Cambridge course on Business and Climate Change : Towards Net Zero Emissions – Very inspiring!
CPI
Head of Business Strategy
Steve is responsible for the strategic direction of CPI’s Electronics business unit and the organisation’s interaction in the Healthtech sector.
Steve’s expertise lies in the areas of sensing, diagnostics, wearables and digitally connected medical devices. Steve has delivered on a number of successful private projects at CPI, helping new research ideas develop through to commercial deployment. Clients include industries such as automotive, aerospace, defence, packaging and medtech. These projects involve working with companies of all sizes ranging from large corporates to SMEs and academia.
Prior to Strategy, Steve held Business Development and Marketing roles at CPI and is currently undertaking an Executive MBA at Warwick Business School.
Genomics England
Strategic Partnerships Director
Dr James Duboff is a Strategic Partnerships Director at Genomics England, driving the translational impact of National genomic and clinical data by partnering with global Pharmaceutical and Biotechnology companies working in Cancer and Rare Disease. He has previously worked in Biopharmaceutical R&D at GlaxoSmithKline and consumer health R&D management at Procter & Gamble, as well as executive leadership roles within a number of UK-based life science focussed start-up and scale-up organisations. Dr Duboff has an Undergraduate and Masters degree in Molecular and Cellular Biochemistry from the University of Oxford and a PhD in Genetics from the University of Cambridge.
NHS Kent & Medway
Chief Digital Transformation Officer
Entrepreneurial business technology leader with a background in healthcare, professional services, property and construction and not for profit sectors.
Key Assignments
Digital and IT Strategy, Product and agile transformation, IT Governance, restructure and target operating model, due diligence of of M&A targets and IT Integration, Cyber Security hardening, Supply Chain Integration, Use of emerging technologies and impact / application on business (Analytics, Machine Learning/AI), Offshore development
CIO Magazine Top 100
Discovery Park
Chief Business Officer
Jane Kennedy joined Discovery Park as Chief Business Officer in June 2021. Her remit is to drive strong business growth through the strategic development of the 220 acre science park; building an innovation hub, fostering a collaborative community on site and driving knowledge exchange.
With a Communication Studies degree, Jane spent the early part of her career working in advertising and marketing. In 2005 she became Marketing Manager of Roslin Biocentre (famed as the home of Dolly the sheep, the world’s first cloned mammal) running the science park and learning about the needs of startup and growing life sciences companies.
As the first employee of BioCity Scotland, she was instrumental in converting an ex-pharma site into BioCity’s first venture outside of Nottingham, launching and co-chairing the Glasgow BioCorridor. Additionally she launched the University of Glasgow’s Clinical Innovation Zone – a centre built around Stratified Medicine and Imaging – at the Queen Elizabeth University Hospital.
Jane has held several Startup support roles assisting early-stage tech-based businesses to build their teams and attract investment. She lives just outside Edinburgh in Scotland and splits her time working from home and travelling to the Discovery Park site in Sandwich, Kent.
Prevention is better than a cure. Can diagnostics devices, early detection, and a better understanding of wellness support the shift from a reactive to proactive healthcare system?
Innovate UK
Deputy Director - Healthy Ageing Challenge
Cynthia Bullock leads the innovation activities across the UK Government’s £98 million Healthy Ageing Challenge supporting the development and delivery of products and services that will allow people to remain active, productive, independent and socially connected across generations for as long as possible.
Cynthia has a background in health research, innovation and commercialisation having trained initially as a Biochemist and Molecular Biologist. Most recently, she led the delivery of Health and Life science programmes at Innovate UK, the UK’s innovation agency representing over £400 million of investment across therapeutics, MedTech, diagnostics and digital health technologies. Cynthia has an executive MBA.
Neuronostics
Managing Director
As managing director of Neuronostics Ltd, I am the strategic lead for the company with overall responsibility for leading the development and commercialisation of its clinical decision support systems and at-home monitoring tools. The company has recently moved its HQ to Bristol, where we are fortunate to be part of the SetSquared community. The potential of our products has been recognised regionally (Medilink SW StartUp award 2020, TechSW Best Healthcare 2020, Medilink SW Innovation award 2021) and nationally (Medilink UK StartUp 2020). To date we have secured over £1.5M in non-dilutive funding and £500K in dilutive funding to support the company’s growth.
University of Leeds
Associate Prof in Clinical Microbiology
I am a Clinical Scientist in Microbiology within Leeds Teaching Hospitals Trust and have been a Visiting Researcher at the University of Leeds since 2015.
I work within the Healthcare Associated Infections (HCAI) Research Group, a multi-organisational (LTHT, UoL, PHE) research team lead by Professor Mark Wilcox.
I obtained my PhD from the University of Leeds in 2001 on “Antibiotics and Clostridium difficile”
I undertook Post-Doctoral work on C. difficile infection from 2001-2005 at the University of Leeds
I trained as a Clinical Scientist in Microbiology in Leeds Teaching Hospitals Trust and was registered with the Health Care Professions Council in 2013.
JMW Biotech
Chief Executive Officer
A true scientist at heart passionate about healthcare & product development.
10 years of research experience in academia and industry. I work closely with product developers, funding organisations and the international community to develop new treatments and diagnostics for infectious diseases. Avid hiker and runner ! Love travelling !
ABHI
Executive Director, Diagnostics
Nishan is responsible for leading ABHI’s strategy to make high quality diagnostic technologies accessible to all who need them. ABHI’s focus on earlier detection and treatment of disease aligns with priorities of the NHS Long Term Plan and the potential for the enhanced use of HealthTech to deliver this is significant. He is an Executive Director of the ABHI Board.
In his time at ABHI Nishan has held a variety of roles including as Chief Operating Officer and has worked on commercial and market access policy issues relevant to the HealthTech industry. His regular, personal interaction with government Ministers, officials and NHS leaders has been key to increasing the Association’s impact. He has extensive knowledge of the HealthTech industry and health/government policy.
Nishan has worked in the health technology industry for 15+ years, and has held senior leadership roles in the industry across finance, marketing and commercial functions.
HealthTech innovations only have real-world benefits when they’re in the hands of the people who need them. How do you develop your regulatory and commercialisation strategy for a smooth journey to market?
Philips, Western Europe
Senior Vice President
Neil is Senior Vice President for the Philips business in Western Europe overseeing the UK, Ireland, Benelux and the Nordic regions. In his 25 years with Philips, Neil has held a number of leadership positions in the company. In his most recent role leading the UK and Ireland, Neil has overseen the transition from the company’s historical role as an electronics and lighting company to becoming one of the largest leading health technology companies focussed on supporting the health of the nation at every stage of people’s lives.
Under Neil’s leadership, Philips has led initiatives to reduce healthcare inequalities, accelerate wide-spread use of sustainable healthcare solutions in support of the NHS’ net zero target and championed the digitisation of the NHS through innovative solutions. This includes launching Philips’ Radiology Operations Command Centres and Community Diagnostic Centres in the UK, both of which will help alleviate the backlog of patients waiting for diagnosis and treatment.
In addition to his role at Philips, Neil is Chair of the Association of British Healthtech Industries.
ABHI
Director, Regulatory and Compliance
Phil started his career at Smith and Nephew qualifying as a Graduate of the Royal Society of Chemistry in 1984, before joining the Company’s Woundcare Regulatory Affairs team at the time when the Medical Device Directive was being enacted. Company moves to Genzyme Biosurgery, Quintiles, Wright Medical Technology and more latterly Kinetic Concepts Inc., (an Acelity company), included work with novel technologies, liaising with National Authorities, the European Commission, Trade Associations and standards bodies on issues related to regulation and ethics.
Phil extended his Trade Association work by joining the ABHI in June 2016 as the Director responsible for regulatory and compliance matters. Phil is a Fellow of TOPRA and lectures at the Sheffield Hallam University on medical device regulatory frameworks. He also chairs the UK BSI’s CH/210 working group which has a mirror relationship to the ISO committee responsible for quality and risk standards.ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
CPI
Director of Health Tech
Rahul is the director of Health Tech business at CPI, which offers end to end innovation development services. We work with mature companies and start-ups to develop transformative ideas into commercial products.
He has 15+ years of global experience working for Johnson & Johnson and Unilever. At J&J, Rahul led growth of medical devices within cardiovascular across EMEA. He worked on the adoption of innovative mental health and infectious pharmaceutical treatments in the NHS.
Recently, at Medicspot, a digital health company, Rahul has been working as the Chief Commercial Officer. Medicspot is creating digital technologies that will improve access and efficiencies within primary healthcare space so everyone can access the right care at the right time. Rahul worked on building up Arc Health, a digital technology business and helped grow Medicspot’s primary healthcare business.
He holds an MBA from London Business School and a Chemical Engineering degree from Indian Institute of Technology, Delhi.
Barts Life Sciences HealthTech
Senior HealthTech Advisor
Dr Sarah Fothergill is lead for the HealthTech Initiative at Barts Life Sciences, and senior HealthTech advisor at Barts Health NHS Trust. Sarah has experience navigating the internal architecture of the NHS and supporting innovation both being developed and deployed alongside the NHS. She has published NHS Innovation Guidance, and continues to work locally and nationally to improve translation of promising technology. Originally from a research and development background, she has hands on experience developing diagnostic tools as a former research associate and understands the challenges many innovators face. She also holds an honorary research fellowship at Queen Mary University of London. Sarah is driven by the desire to improve the NHS by solving issues that matter the most to NHS patients and staff.
In a competitive and fast-growing healthcare sector, how do you secure funding for innovative ideas? What do potential investors want to hear and see from HealthTech entrepreneurs?
J A Kemp
Partner
Stephen is a patent attorney with over 20 years of experience in drafting, prosecuting and contesting patents and advising clients ranging from local start-ups and SMEs, through universities in the UK and elsewhere, to multi-national companies. With a background in physics and a leaning towards the mathematical side of that, a significant portion of Stephen’s work has been in the MedTech field. This has ranged from devices and analytics to the application of computation solutions in bioinformatics applications such as genomics and computational approaches to diagnosis and drug discovery.
TBAT Innovation Ltd
Director
After establishing TBAT in 2002 as a consultancy catering to the SME sector, Sam led the company’s evolution into the innovation-centric enterprise it is today. TBAT now specializes in supporting companies throughout the entire new product and process innovation cycle. Sam began his career as a graduate and manufacturing engineer at Rolls-Royce Aerospace before transitioning to Rolls Royce and Associates as a Development and Project Engineer. Currently, Sam heads up the Business Development and R&D Tax Credits side of the business.
Oxford Dynamics
Co-Founder & Director
Mike Lawton is a serial entrepreneur, who enjoys building early-stage, deep tech businesses in demanding environments. His biggest success to date is Oxford Space Systems, founded in 2013 and now seen as strategically important to the UK space sector and one of the highest-valued space start-ups in the UK. Currently a Co-Founder & Director in two new ventures:
Mike is a keen supporter of STEM subjects, with a particular passion for inspiring the next generation of entrepreneurial engineers and scientists.
* Barclay’s Bank UK Start-Up Tech Entrepreneur 2018
*Featured in Engineers Making a Difference Book
*Mentor for 2021 Santander Breakthrough Women Business Leaders’ Mentoring Programme
How does the HealthTech sector fit into the NHS’ ambitious Net Zero plan? Innovative technology can help us make the sector greener, but with an increased number of devices, single-use plastics, and energy-intensive data processing and storage, what challenges does the sector face?
Mills & Reeve
Partner and Head of Life Sciences
James heads Mills & Reeve’s multi-disciplinary life sciences practice. He supports businesses across the full product lifecycle, from start-up to commercialisation.
A key focus of his work is supporting clients on strategic contracting covering technology / IP in and out- licensing transactions, research collaborations, clinical trial agreements and long term partnering agreements. James also advises on sector regulation including pharma and medical device regulation, market access, borderline products, advertising and clinical trials.
IEMA
Chief Executive Officer
Martin Baxter FIEMA, CEnv, FRSA
IEMA – Institute of Environmental Management & Assessment
Martin Baxter is Policy and External Affairs Director and Deputy CEO at the Institute of Environmental Management and Assessment (IEMA). He works in the UK and internationally to support the transition to a low carbon, resource efficient and sustainable economy and reverse the decline of the natural environment.
Martin has national and international experience in developing and negotiating global and European environmental management standards and developing capacity for effective and widespread implementation. Martin heads the UK delegation to the International Organisation for Standardisation (ISO) on environmental management and chairs the ISO environmental management systems committee of ~100 countries. He is also vice-chair of the European Standards CEN/CENELEC Strategic Advisory Body on the Environment.
Martin is a Board member of IEMA and the Society for the Environment (SocEnv), and a member of the Government’s Green Jobs Delivery Group.
ABHI
Sustainability Executive
After studying Philosophy and Management at the University of Leeds, Addie undertook a Masters in Sustainability and Management at Royal Holloway. In becoming ABHI’s first Sustainability Executive, Addie will lead the Association’s work on this critical agenda, providing support to the membership and working with stakeholders to ensure the role of sustainability within HealthTech is recognised. ABHI has also produced a Sustainability Framework for Action, developed to aid ABHI members with their own sustainability journey.
Boston Scientific
Head Of Public Affairs
Currently on a mission re Environmental Sustainability. Net zero a must.
20 plus years in Medical devices: sales, management, marketing, Market Development & Market Access.
PG Diploma in Health Economics York University gave me a platform to move into Health Economics, Policy and Reimbursement. My work in Public Affairs is now linked to my focus on Environmental Sustainability.
I chair the ABHI Sustainability group, Vice-chair the Commercial policy group, and sit on the Board of HealthTech Ireland.
Passed course from University of Cambridge course on Business and Climate Change : Towards Net Zero Emissions – Very inspiring!
52 North Health
Head of Product Development
Dr Ama Frimpong is a multi-award-winning engineer, who is Head of Product Development and leads Regulatory Strategy at 52 North Health Ltd.
She leads the company’s engineering teams and the development of NeutroCheck, a low-cost, transformative in vitro diagnostic which will support remote triage of cancer patients at risk of life-threatening neutropenic sepsis.
She has spent her career at the forefront of healthcare innovations and has significantly contributed to the technical development of a vast array of products and processes, as a consultant engineer and researcher. She holds a PhD in Medical and Biological Engineering from the University of Leeds and is the IET Young Woman Engineer of the Year for 2022.
Pennine Healthcare
Chief Executive Officer
Graeme is CEO of Pennine Healthcare, a UK based manufacturer and distributor of medical devices critical to the protection and improvement of life. Graeme took up this role at the transition stage of Pennine Healthcare becoming Employee Owned in 2021.
Previous to Pennine Healthcare, Graeme was Managing Director of B Braun Avitum and was Head of the B Braun Hospital Care Division & Veterinary Division. B Braun are a global service provider and supplier of medical technology and pharmaceuticals. His function incorporated sales, marketing, manufacturing and operations. Alongside this role Graeme was part of the B. Braun UK Group Board, Executive Committee and Global Network Teams.
Outside of Pennine Healthcare, Graeme Chair’s the Association of British Healthcare Industry Commercial Policy Group which has a focus on realising value-based procurement within the NHS so that technology and innovation can drive improved patient outcomes. Graeme also Chair’s the Advisory Panel of the Derby County Community Trust Princes’ Trust SCORE programme supporting young people into careers within Health and Social Care and he sits on the University of Derby Business, Law & Social Sciences Advisory Board.
Graeme vice – chairs the NHS England SME Advisory Group which has the goal of better engaging, communicating and learning from the SME community to encourage SME’s participation in commercial activity to maximise their innovation power for the benefit of patients and the NHS.
Graeme holds two degrees – one from the University of Aberdeen and a Master’s in Business Administration (EMBA) from the University of Leeds and is currently studying for his Turnaround Management Association (TMA) qualifications.
Graeme is married with two children and enjoys sport and health.
Developing a HealthTech device requires a huge diversity of skills in health, biology, chemistry, technology, engineering, computing and more. How do we create a multidisciplinary ecosystem that supports innovation?
UKRI Science and Technology Facilities Council
Head of Clusters (NW)
For the last couple of years Phil has had the pleasure of working with colleagues and stakeholders in developing High-Tech. regional innovation clusters, in key strategic sectors for the UK. This includes setting up and leading the North West of England’s Health and Life sciences Cluster (HealthTech) and establishing other clusters in sectors such as Space.
The clusters exist to connect key capabilities between stakeholders, national science facilities and innovators in the wider ecosystem to support collaboration, cross-sector innovation and community building.
A scientist by background, he undertook a PhD for the European Space Agency at King’s College London, conducting numerous studies on a SkinSuit which was designed to support astronauts in space and reduce the risk of spinal issues post flight. This has subsequently been used on several astronaut missions.
Passionate about cross sector opportunities, including Health & Space, for 5 years he coordinated the UK’s Space Life and Biomedical Science Association, which among other core activities he led the development of the UK Position Paper ‘Why Space? The opportunity for Health & Life Science Innovation”. He currently chairs the UK’s Regional Space Cluster Advisory board and at a European Level serves as the elected President for the European Low Gravity Research Association (ELGRA).
WeWALK
Head of Research and Development
Dr Jean Marc Feghali – Head of Research and Development at WeWALK
Being visually impaired and obtaining a PhD in the mobility of visually impaired people at Imperial College London, Jean Marc is driven by the life-changing potential of his research and its impact on assistive technology. Jean Marc leverages his findings in the development of the WeWALK smart cane, a TIME best invention of 2019, through managing multi-million-pound R&D collaborations with world-leading partners including Microsoft and RNIB.
Jean Marc also regularly advises on transport accessibility and sits on Transport for London’s IDAG advisory board for disability and inclusion, as well as conducting novel mobility research that has been recognised through an Imperial College Medal for Outstanding Achievement, the Walter Redlich Prize for Academic Excellence, and the Royal Institute of Navigation for an Outstanding Contribution to a More Navigable World.
Element Materials Testing
Director, Medical Technologies EMEAA
Michael is Director, Medical Technologies EMEAA for Element Materials Testing which is a global testing, inspection, calibration and certification business. Element work with a broad range of health technology businesses to proactively support them to get to market and manufacture products that are as safe as practically possible.
Previously, Michael worked for Innovate UK for four years as a Health Innovation Lead and was responsible for the management of a UK government grant funding programme called the Biomedical Catalyst that provided £30M per annum to supports UK SMEs developing innovative health & life science products. Before joining Innovate UK, Michael was a Group Manager at Medicines & Healthcare Products Regulatory Agency (MHRA) where he led a team that was responsible for safety & surveillance of all medical devices in UK. He also spent 10 years in the medical device industry in a range of commercial roles working for Guidant, Boston Scientific and BIOTRONIK where he was Country Director UK & Eire.
Genomics England
Strategic Partnerships Director
Dr James Duboff is a Strategic Partnerships Director at Genomics England, driving the translational impact of National genomic and clinical data by partnering with global Pharmaceutical and Biotechnology companies working in Cancer and Rare Disease. He has previously worked in Biopharmaceutical R&D at GlaxoSmithKline and consumer health R&D management at Procter & Gamble, as well as executive leadership roles within a number of UK-based life science focussed start-up and scale-up organisations. Dr Duboff has an Undergraduate and Masters degree in Molecular and Cellular Biochemistry from the University of Oxford and a PhD in Genetics from the University of Cambridge.
Team Consulting
Technical Director
Chris joined Team Consulting in 1994 with a mechanical engineering background in the offshore industry and now has almost thirty years of product innovation experience in the healthcare sector. He combines technical input and review with business development, management and leadership activities. His experience covers all stages of product life cycle from direction setting to post launch support, working with companies ranging from small start-ups to large multi-national organisations.
Chris has particular expertise in the design, development and industrialisation of drug delivery devices including dry powder and pressurised metered dose inhalers and injection systems including pen injectors, auto-injectors, needle-free injectors and on body delivery systems. He has also worked on the development of surgical, diagnostic and medtech products and systems. Chris has extensive experience in the field of engineering analysis, design verification and risk management and has written and presented numerous articles and papers covering all aspects of medical device development. He is a long standing member of ISO technical committee TC84 covering device for administration of medicinal products and catheters.
In his previous role of Director of Engineering he was responsible for the ongoing quality and continuous improvement of Team’s overall engineering offering including mechanical, electro-mechanical, electronics and software engineering and applied science. In his current role of Technical Director he works more broadly across all discipline groups including Design, Human Factors, Device Testing and Programme Management, to help ensure consistent excellence of project delivery for all of Team’s clients.
Generative AI and digital twins are set to revolutionise the future of HealthTech in medical device product development. With Generative AI spearheading the smart technology revolution, digital technologies will make medical devices preventative, personalised and adaptive, leading to new disruptive, data-driven, business models.
This session will explore the commercialisation and adoption of medical devices; from accelerated product development through generative AI to digital twin technologies; generating health and financial benefits through computational models of patient pathways, and investment opportunities, through the launch of in silico clinical trials.
CPI
Head of Business Strategy
Steve is responsible for the strategic direction of CPI’s Electronics business unit and the organisation’s interaction in the Healthtech sector.
Steve’s expertise lies in the areas of sensing, diagnostics, wearables and digitally connected medical devices. Steve has delivered on a number of successful private projects at CPI, helping new research ideas develop through to commercial deployment. Clients include industries such as automotive, aerospace, defence, packaging and medtech. These projects involve working with companies of all sizes ranging from large corporates to SMEs and academia.
Prior to Strategy, Steve held Business Development and Marketing roles at CPI and is currently undertaking an Executive MBA at Warwick Business School.
Mills & Reeve LLP
Principal Associate
Stephanie is a lawyer in the Mills & Reeve LLP life sciences team, with experience in intellectual property, data protection, commercial contracting and regulatory work. She supports a wide variety of clients in the sector across the full product life cycle.
Her work includes advising on research and development agreements, collaborations and intellectual property licences. A key focus of her work is supporting clients on strategic decisions influenced by the regulatory framework, development and licensing of products, research collaborations and data protection implications in research and clinical trials, including cross-border issues.
Stephanie has supported her clients in connection with their efforts to respond to, and develop treatments for, major epidemic and pandemic threats over the past decade, including collection and transfer of patient samples internationally.
SEHTA
Chief Executive Officer,
Neil was appointed as CEO on 1st April 2021, having previously been our COO since July 2018.
He has spent more than 25 years in the medical technology market, with a track record of success in driving business development and growth, via sales and marketing, domestic and international distributor management, market access, major accounts, new business integration, and change management, gained in the UK and in export within an SME and leading MedTech company environment.
His areas of expertise cover a large range of medical applications and technologies including; Ophthalmic imaging, diagnosis and consumables, Cardiology, Oncology treatment, Care of the Elderly, Surgical visualisation and lasers, Wound care, Anaesthesia delivery and theatre monitoring, Dermatology, Colposcopy, ENT, and EEG/EMG/EP in neurology.
Precisia Life Sciences, a C2-Ai business
Chief Medical Officer and Business Unit Director
Sheuli is a highly experienced and respected leader in life sciences.
Sheuli originally trained in medicine at Cambridge and Oxford then worked in the NHS before moving to pharmaceutical medicine. Sheuli has worked internationally in medical affairs, clinical development and life science policy.
She is the Vice President of the Faculty of Pharmaceutical Medicine, a Fellow of the Royal College of Physicians of London and a Global Fellow in Medicines Development with IFAPP.
Sheuli is a member of the Steering Group for the UKRI Multiple Long-Term Conditions Programme, the AoMRC Genomics Professional Partnerships Group and the UK Pharmacogenetics and Stratified Medicine Network Steering Group.
Sheuli is also a visiting lecturer at King’s College London.
Level39 offers ambitious tech businesses the tools they need to have a global financial and social impact. A diverse network of entrepreneurs, pioneering everyday wealth, health and security. Our flexible co-working, private office space and ecosystem activities provide members with access to the environment and growth opportunities they need to develop into world-leading businesses. Level39 is where great minds don’t think alike.
Canary Wharf Group (CWG) is the developer of the largest urban regeneration project in Europe. CWG develops, manages and currently owns interests in approximately 9 million square feet of mixed-use space and over 1,100 Build to Rent apartments.
Kadans Science Partner (Kadans) is the European leader investing in the development of ecosystems and real estate with a dedicated focus on the knowledge intensive sector. Kadans is present on 26 campuses, in 6 countries, where it operates over 7 million sq ft of space for over 400 tenants, including start-ups, scale-ups, corporates, government bodies and educational institutes.
Canary Wharf is accessible through using the Jubilee Line, the Elizabeth Line and Docklands Light Railway services. The River Services Interchange is also available for River Bus options.
